Results

Total Results: 937 records

Showing results for "question".

301. Evidence Summary: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
     September 28, 2021 - Key Question 1a. … Benefits on Preeclampsia Prevention Key Question 2. … Key Question 2a. … Harms Key Question 3. … Key Question 3a.

302. Draft Research Plan: Sexually Transmitted Infections: Behavioral Counseling | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/sexually-transmitted-infections
     January 16, 2025 - post-exposure prophylaxis; HIV = human immunodeficiency virus; HSV = herpes simplex virus; KQ = key question

303. Evidence Summary: Iron Deficiency Anemia in Young Children: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary23/iron-deficiency-anemia-in-young-children-screening
     March 30, 2015 - Studies were selected on the basis of inclusion and exclusion criteria developed for each Key Question … The aggregate quality of the body of evidence for each Key Question (i.e., good, fair, poor) was assessed … c Some studies are included for >1 Key Question (KQ). d Includes 2 poor-quality studies. … For Key Question 1 on routine iron supplementation, 6 trials were included for growth outcomes, 4 trials … For Key Question 2, 2 trials were included on harms of supplementation.

304. Final Research Plan: Sexually Transmitted Infections: Behavioral Counseling | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/sexually-transmitted-infections
     May 01, 2025 - post-exposure prophylaxis; HIV = human immunodeficiency virus; HSV = herpes simplex virus; KQ = key question

305. Draft Research Plan: Vision in Children Ages 6 Months to 5 Years: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/vision-screening-children-ages-6-months-5-years
     April 24, 2025 - screening modality, and intervention characteristics of the included studies, as appropriate for each Key Question

306. Archived: Final Evidence Summary: Child Maltreatment: Primary Care Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary13/child-maltreatment-primary-care-interventions-2013
     January 15, 2013 - Data Synthesis We assessed the aggregate quality of the body of evidence for each key question as good … Key Question 2 What are the adverse effects of behavioral interventions and counseling to reduce harm … From this population, an arrow represents interventions initiated in primary care settings (key question … For key question 1, 11 trials were included, and additional trials from the prior report are discussed … For key question 2, no studies were included.

307. Evidence Summary: Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary--html/cardiovascular-disease-screening-using-nontraditional-risk-assessment
     July 10, 2018 - Benefits of Risk Assessment Key Question 1. … Performance Characteristics of Risk Assessment Measures Key Question 2. … Harms of Risk Assessment Key Question 3. … Key Question 5. What are the harms of treatment guided by nontraditional risk factors? … That analysis, while valid, was designed to answer a different question about risk stratification and

308. Primary Care Interventions to Prevent Child Maltreatment: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/DPq7_eawq-Ts6XLowaTaNA
     November 27, 2018 - Refer to the USPSTF Procedure Manual for further details.11 KQ indicates key question. … a contextual question (eResults 2 in the Supplement). … KQ1 and KQ2 177 Citations identified through other sources (eg, reference lists) KQ indicates key question … visits, when re- ported, ranged from 5 sessions49 to 41 sessions.34,35 Benefits of Interventions Key Question … NA Insufficient NA Abbreviations: CPS, child protective services; ED, emergency department; KQ, key question

309. Evidence Summary: Ovarian Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/ovarian-cancer-screening
     February 13, 2018 - for ovarian cancer as defined above. 18 The strength of the overall body of evidence for each key question … Benefits of Screening Key Question 1. … with ovarian cancer did not differ significantly between study groups. 21 Harms of Screening Key Question … Effects of Ovarian Cancer Screening on Ovarian Cancer Mortality (Key Question 1)^{Question 2)}

310. Archived: Evidence Summary: Hepatitis C Virus Infection: Screening, 2004 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/hepatitis-c-virus-infection-screening-2004
     March 08, 2004 - We rated the overall body of evidence for each key question using the system developed by the USPSTF. … For key question 2, we included large observational studies that used appropriate statistical methods … For key question 5b, we included clinical trials and observational studies that reported the number of … For question 7b, controlled trials of non-pegylated interferon without ribavirin were also included if … We rated the overall body of evidence for each key question using the system developed by the USPTF.

311. Final Research Plan: Oral Health in Children and Adolescents Aged 5 to 17 Years: Screening and Preventive Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/oral-health-children-adolescents-screening-preventive-interventions
     June 17, 2021 - *This is the same as Key Question 2b from the previous Analytic Framework.

312. Folic Acid Supplementation to Prevent Neural Tube Defects: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/4TToeya43r5Qc5A6TjFGWS
     August 01, 2023 - Evidence From Limited Update Review: Folic Acid Supplementation to Prevent Neural Tube Defects Key question … From Limited Update Review: Folic Acid Supplementation to Prevent Neural Tube Defects (continued) Key question … From Limited Update Review: Folic Acid Supplementation to Prevent Neural Tube Defects (continued) Key question … NA Abbreviations: aOR, adjusted odds ratio; aRR, adjusted relative risk; HR, hazard ratio; KQ, key question

313. Final Research Plan: Speech and Language Delay and Disorders in Children: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/speech-and-language-delay-and-disorders-in-children-age-5-and-younger-screening
     June 09, 2022 - Abbreviations: KQ=key question; RCT=randomized, controlled trial.

314. Draft Research Plan: Autism Spectrum Disorder in Young Children: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/autism-spectrum-disorder-young-children-1
     February 25, 2021 - good-quality studies Poor-quality studies Abbreviations: ASD=autism spectrum disorder; KQ=key question

315. Screening for Hypertension in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/QaNSteuunshjz-kHPxVvAN
     April 27, 2021 - Benefits of Screening Key Question 1. … Test Accuracy Key Question 2. … Key Question 2a. What screening protocol characteristics define the best test accuracy? … Key Question 3. … Key Question 3a. What confirmation protocol characteristics define the best test accuracy?

316. Preeclampsia Screening Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/LgA7neX9UurPQRh3pJaYXY
     April 25, 2017 - Screening Harms Key Question 5. … 1a and Key Question 5) Source, Study Designa Outcome Category Outcome No. … Accuracy of Screening Tests Key Question 4a. … Risk Prediction Key Question 2. … Key Question 3. What are the harms of preeclampsia risk prediction?

317. Screening for Asymptomatic Bacteriuria in Adults: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/8YfPLRoMwTeaDgxJdYnYbb
     September 24, 2019 - KQ indicates key question. … Effectiveness of Screening Key Question 1. … Harms of Screening Key Question 2. What are the harms of screening for asymptom- atic bacteriuria? … Effectiveness of Treament Key Question 3. … Summary of Evidence by Key Question and Population Population Studies, Study Designs Summary of Findings

318. Screening for HIV Infection in Asymptomatic, Nonpregnant Adolescents and Adults: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/q_zxLD9JZFGoSPCrEHNk2g
     June 11, 2019 - KQ indicates key question; USPSTF, US Preventive Services Task Force. … Screening Key Question 1. … Key Question 2. … Key Question 3. … Longer-Term Harms of Treatment Key Question 5.

319. JAMA (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/GcjfCZtGpACQMv2KScLbEu
     June 11, 2019 - Key Question 2. … Key Question 3. What are the harms of screening for HIV infection in pregnant women? … Effectiveness of Treatment Key Question 4. … Harms of Treatment Key Question 5. … KQ indicates key question; USPSTF, US Preventive Services Task Force.

320. Archived: Evidence Summary: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-latent-tuberculosis/latent-tuberculosis-infection-screening-september-2016
     September 06, 2016 - Benefits of Screening Key Question 1. … Accuracy and Reliability of Screening Tests Key Question 2. … Benefits of Treatment Key Question 3. … Harms of Screening Key Question 4. Are there harms associated with screening for LTBI? … Harms of Treatment Key Question 5.